Manager of the Finsbury Growth and Income trust Nick Train has increased his position in Fever-Tree, despite the soft drinks manufacturer delivering the worst performance across the portfolio in July.
In the latest monthly report, Train revealed he had bought more shares in the beverage producer after they fell 12% on a profit warning related to transportation and glass costs ahead of its H1 results. Nick Train uses DMGT cash to top up Fever-Tree and Experian The manager said he is confident about the company's secular growth opportunity in all its markets, especially in the US, and applauded management for "doing the right thing for the business". "It would be quite wrong for the company to protect its profit margins in current circumstances," he said. Such measures could incl...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
